P&G, Teva go full bore at OTC market; GSK vaccine picked for U.K. children's campaign;

@FiercePharma: In $491mn Rapamune settlement, Pfizer to plead guilty to a misdemeanor. News | Follow @FiercePharma

> Procter & Gamble ($PG) and Teva Pharmaceutical Industries ($TEVA) announced regulatory approval for a joint venture to sell over-the-counter drugs with expectation of of $4 billion in annual sales by the end of the decade. Story

> Authorities have picked GlaxoSmithKline's ($GSK) Rotarix vaccine for its first routine immunization program in Britain to protect children against rotavirus, the highly contagious stomach flu. Story 

> Wyeth, a unit of Pfizer ($PFE), intends to pay $491 million and plead guilty to a misdemeanor of "misbranding" to settle a probe into the organ-transplant drug Rapamune. Story 

> Brazil's Hypermarcas posted a profit in the third quarter as sales improved. Story

Medical Device News

 @FierceMedDev: EarlySense in Israel raised $15M for hospital beds with sensors built in--via Globes. More | Follow @FierceMedDev

 @MarkHFierce: HeartWare boosted revenue in Q3 2012, thanks to expanded Int'l approval for its HVAD device. But net losses soared. More | Follow @MarkHFierce

 @DamianFierce: Covance took a 7% profit hit in Q3 but still topped Wall Street estimates. More | Follow @DamianFierce

> Qualcomm extends its medical device network to Europe. Report

> EarlySense pulls in $15M to boost patient monitoring tech sales. Story

> Sorin Group acquires Belgian neurostim device maker. News

Biotech News

 @FierceBiotech: From FierceCRO.com: Icon launches new functional service model. More | Follow @FierceBiotech

 @JohnCFierce: How about that--AstraZeneca gets pos. data in late-stage constipation study. Partnered with Nektar ('09 1.5B deal). More | Follow @JohnCFierce

 @RyanMFierce: Boehringer Ingelheim takes hepC message online. News | Follow @RyanMFierce

> CV fears cloud AstraZeneca's positive results for $1.5B constipation program. Article

> Abbott, Gilead impress with upbeat results for oral hep C drugs. Report

> Shares of Clovis, Clavis blasted by failure of pancreatic cancer drug. Story

> Tau theory comes center stage in Alzheimer's R&D as amyloid advocates regroup. News

Biotech IT News

> GNS turns to Big Data to crack multiple myeloma. News

> FDA updates IT after GAO lashing. Item

> Boehringer Ingelheim takes hep C message online. Article

> Private equity interest in Merge prompts breakup speculation. Story

> Maverix enters genomics software game with Silicon Valley sizzle. Report

CRO News

> Parexel looks to the future with university partnership. Item

> Covance posts profit drop but beats predictions in Q3. Story

> DiscoveRx snags BioSeek for drug development. News

> CRA buys Radiant Research to increase trial capacity. Article

> AMRI narrows losses on strong Q3. News

And Finally... Ranbaxy Laboratories is looking to consultants to tell it how it is doing at its Dewas manufacturing plant, one of the facilities cited in an FDA consent decree. Story

 

Suggested Articles

GlaxoSmithKline, its agency McCann Health, and their "Breath of LIfe" smartphone app took the Grand Prix in pharma last night at Cannes Lions Health.

P&G, the packaged goods giant that bought Merck KgAA’s consumer unit, is out in force at Lions Health. Is that a message for rivals?

Jazz Pharma's next drug launch is set for early July after a DEA scheduling for sleepiness drug Sunosi.